Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Brexanolone by Seaport Therapeutics for Major Depressive Disorder: Likelihood of Approval
Brexanolone is under clinical development by Seaport Therapeutics and currently in Phase II for Major Depressive Disorder. According to GlobalData,...